全文获取类型
收费全文 | 106192篇 |
免费 | 9385篇 |
国内免费 | 4644篇 |
专业分类
耳鼻咽喉 | 1454篇 |
儿科学 | 1307篇 |
妇产科学 | 1689篇 |
基础医学 | 15436篇 |
口腔科学 | 2440篇 |
临床医学 | 10865篇 |
内科学 | 19038篇 |
皮肤病学 | 1786篇 |
神经病学 | 6990篇 |
特种医学 | 4376篇 |
外国民族医学 | 27篇 |
外科学 | 13215篇 |
综合类 | 10122篇 |
现状与发展 | 14篇 |
一般理论 | 10篇 |
预防医学 | 6036篇 |
眼科学 | 2661篇 |
药学 | 10199篇 |
38篇 | |
中国医学 | 3170篇 |
肿瘤学 | 9348篇 |
出版年
2024年 | 150篇 |
2023年 | 935篇 |
2022年 | 2384篇 |
2021年 | 3535篇 |
2020年 | 2503篇 |
2019年 | 2613篇 |
2018年 | 3128篇 |
2017年 | 2677篇 |
2016年 | 2661篇 |
2015年 | 3596篇 |
2014年 | 4323篇 |
2013年 | 4534篇 |
2012年 | 6384篇 |
2011年 | 6574篇 |
2010年 | 4023篇 |
2009年 | 3447篇 |
2008年 | 4765篇 |
2007年 | 4805篇 |
2006年 | 4487篇 |
2005年 | 4018篇 |
2004年 | 3215篇 |
2003年 | 3028篇 |
2002年 | 2678篇 |
2001年 | 5690篇 |
2000年 | 5606篇 |
1999年 | 5007篇 |
1998年 | 1972篇 |
1997年 | 1585篇 |
1996年 | 1074篇 |
1995年 | 920篇 |
1994年 | 827篇 |
1993年 | 627篇 |
1992年 | 2271篇 |
1991年 | 1942篇 |
1990年 | 1782篇 |
1989年 | 1714篇 |
1988年 | 1503篇 |
1987年 | 1363篇 |
1986年 | 1207篇 |
1985年 | 1005篇 |
1984年 | 657篇 |
1983年 | 528篇 |
1982年 | 274篇 |
1981年 | 212篇 |
1980年 | 159篇 |
1979年 | 315篇 |
1978年 | 98篇 |
1976年 | 98篇 |
1974年 | 100篇 |
1973年 | 113篇 |
排序方式: 共有10000条查询结果,搜索用时 31 毫秒
41.
Darren R. Feldman MD Yasser Ged MBBS Chung-Han Lee PhD Andrea Knezevic MS Ana M. Molina MD Ying-Bei Chen PhD Joshua Chaim DO Devyn T. Coskey MS Samuel Murray MS Satish K. Tickoo MD Victor E. Reuter MD Sujata Patil PhD Han Xiao MD Jahan Aghalar MD Arlyn J. Apollo MD Maria I. Carlo MD Robert J. Motzer MD Martin H. Voss MD 《Cancer》2020,126(24):5247-5255
42.
43.
44.
45.
Zhengxian Huang Nan Xie Haichao Liu Yuehan Wan Yue Zhu Ming Zhang Yifan Tao Han Zhou Xiqiang Liu Jinsong Hou Cheng Wang 《Journal of oral pathology & medicine》2019,48(9):788-798
It has been suggested that tumour‐infiltrating lymphocytes (TILs) are associated with the progression of oral squamous cell carcinoma (OSCC). However, the prognostic value of TILs is inconclusive due to the heterogeneity of immune cells within the tumour microenvironment. In this meta‐analysis, we aimed to assess the prognostic value of TILs in OSCC. The PubMed, Cochrane, Embase, Scopus and Web of Science databases were searched up to April 20, 2019, and 33 studies were ultimately included in this meta‐analysis. Our pooled meta‐analysis showed that high infiltration of CD8+ TILs, CD45RO+ TILs and CD57+ TILs favoured better overall survival (OS). However, high infiltration of CD68+ macrophages and CD163+ macrophages was associated with poor prognosis in OSCC. These findings suggest that CD8+ TILs, CD45RO+ TILs, CD57+ TILs, CD68+ macrophages and CD163+ macrophages might serve as novel prognostic factors and therapeutic targets in OSCC. 相似文献
46.
47.
J Phua E S C Koay D Zhang L K Tai X L Boo K C Lim T K Lim 《The European respiratory journal》2006,28(4):695-702
Levels of the soluble form of the triggering receptor expressed on myeloid cells (sTREM)-1 are elevated in severe sepsis. However, it is not known whether sTREM-1 measurements can distinguish milder bacterial infections from noninfectious inflammation. The present authors studied whether serum sTREM-1 levels differ in community-acquired pneumonia, exacerbations of chronic obstructive pulmonary disease (COPD), asthma and controls, and whether sTREM-1 may be used as a surrogate marker for the need for antibiotics. Serum sTREM-1 levels in 150 patients with pneumonia, COPD and asthma exacerbations and 62 healthy controls were measured. Serum sTREM-1 levels were significantly elevated in pneumonia (median 295.2 ng x mL(-1)), COPD (280.3 ng x mL(-1)) and asthma exacerbations (184.0 ng x mL(-1)) compared with controls (83.1 ng x mL(-1)). Levels were higher in pneumonia and Anthonisen type 1 COPD exacerbations than in type 2 and 3 COPD and asthma exacerbations. The area under the receiver operating characteristics curve for sTREM-1 as a surrogate marker for the need for antibiotics was 0.77. Serum levels of the soluble form of the triggering receptor expressed on myeloid cells-1 were elevated predominantly in pneumonia and Anthonisen type 1 COPD exacerbations versus type 2 and 3 chronic obstructive pulmonary disease exacerbations, asthma and controls. Serum levels of the soluble form of the triggering receptor expressed on myeloid cells-1 has moderate but insufficient accuracy as a surrogate marker for the need for antibiotics in lower respiratory tract infections. 相似文献
48.
H J Kim C H Kang Y T Kim S-W Sung J H Kim S M Lee C-G Yoo C-T Lee Y W Kim S K Han Y-S Shim J-J Yim 《The European respiratory journal》2006,28(3):576-580
Although surgical lung resection could improve prognosis in some patients with multidrug-resistant tuberculosis (MDR-TB), there are no reports on the optimal candidates for this surgery. The aim of the present study was to elucidate the prognostic factors for surgery in patients with MDR-TB. Patients who underwent lung resection for the treatment of MDR-TB between March 1993 and December 2004 were included in the present study. Treatment failure was defined as greater than or equal to two of the five cultures recorded in the final 12 months of treatment being positive, any one of the final three cultures being positive, or the patient having died during treatment. The variables that affected treatment outcomes were identified through univariate and multivariate logistic regression analysis. In total, 79 patients with MDR-TB were included in the present study. The treatment outcomes of 22 (27.8%) patients were classified as failure. A body mass index <18.5 kg x m(-2), primary resistance, resistance to ofloxacin and the presence of a cavitary lesion beyond the range of the surgical resection were associated with treatment failure. Low body mass index, primary resistance, resistance to ofloxacin and cavitary lesions beyond the range of resection are possible poor prognostic factors for surgical lung resection in multidrug-resistant tuberculosis patients. 相似文献
49.
Neprilysin基因在大鼠体外培养骨髓基质细胞中的表达 总被引:1,自引:1,他引:0
目的探讨人Neprilysin基因在小鼠MSCs中的表达情况。方法分离培养小鼠MSCs,采用分子克隆技术构建Neprilysin—pEGFP重组质粒,将此Neprilysin—pEGFP重组质粒用脂质体转染进MSCs中,在荧光倒置显微镜下观察该基因在MSCs中的表达效率。结果经酶切鉴定得到系列正确的重组Neprilysin—pEGFP。Neprilysin可在MSCs中表达且通过脂质体传染的效率是20%。结论获得了表达Neprilysin基因的骨髓基质细胞,为进一步探讨将该细胞用于阿尔茨海默病基因治疗的可能性研究提供了技术基础。 相似文献
50.